Topical formulations represent 73% of formulation type sales and respiratory disorders account for 27% within the application segment in 2026. The pharma grade synthetic camphor market is estimated at USD 484.1 million in 2026, is projected to reach USD 703.0 million by 2036 and is forecast to post a 3.8% CAGR between 2026 and 2036.